🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis

RecruitingPhase 3Ages 50 Years - anyAllSherief Abd-Elsalam
NCT04704947 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Clinical study evaluating selective or nonselective beta blockers use and fracture risk in patients with primary osteoporosis

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * • Male \& female osteoporotic patient aged ≥ 50 years * Hypertensive \& normotensive patients * BMD T-score ≥ 2.5 or more SD below peak bone mass Exclusion Criteria: * Patients on drugs that may improve osteoporosis disease state such as: * Angiotensin converting enzyme inhibitor (ACEI) or Angiotensin receptor blockers (ARBs), Thiazide diuretic, Nitrates, Spironolactone, Statins. Patients on drugs that may worsen osteoporosis disease state such as: • Corticosteroids, Loop diuretics, Anticonvulsants, Antidepressants, Aromatase inhibitors, Thyroid replacement therapy and Proton pump inhibitors.
💊

What it tests

  • nonselective beta blocker
  • cardio-selective beta blocker group
  • alendronate sodium
📍

Where

1 site
Sherief Abd-Elsalam
Tanta, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy